Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in CTNM — Contineum Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in CTNM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,238,412
-$3,615,154 QoQ
Shares Held
75,559
-79.7% QoQ
Ownership
0.201%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 101 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CTNM Over Time

Shares Held

Position Value (USD)

Derivatives in CTNM

reported options exposure · as of Jun 30, 2026
CallValue
$234,377
CallShares
14,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,650,012,247 across 349 Biotechnology names. CTNM ranks #114 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CTNM

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $234,377 14,300
2026-06-30 $1,238,412 75,559
2026-03-31 $147,578 11,300
2026-03-31 $4,853,566 371,636
2025-12-31 $116,586 10,200
2025-12-31 $3,037,648 265,761
2025-09-30 $2,398,398 204,119
2025-06-30 $79,920 20,131
2025-03-31 $92,533 13,257